Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MCRB | MRNA | BMY | AMGN | GILD |
| Company | Seres Therapeutics Inc | Moderna Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.7132 | 107.43 | 47.39 | 273.45 | 67.47 |
| High | 0.8290 | 108.23 | 47.50 | 274.35 | 67.90 |
| Low | 0.7002 | 103.52 | 44.67 | 267.24 | 65.32 |
| Last | 0.7407 | 104.91 | 44.72 | 267.97 | 65.41 |
| Change | +0.0112 | -3.94 | -4.14 | -5.04 | -1.67 |
| % Change | +1.54% | -3.62% | -8.47% | -1.85% | -2.49% |
| Volume | 2,371,286 | 1,387,293 | 22,488,887 | 557,792 | 4,165,221 |
| 20-Day Average Volume | 4,510,093 | 3,066,226 | 11,686,238 | 2,086,259 | 6,306,002 |
| Previous Close | 0.7295 | 108.85 | 48.86 | 273.01 | 67.08 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6955 | 104.92 | 49.96 | 270.65 | 68.70 |
| 20-Day Raw Stochastic | 74.60% | 40.44% | 4.64% | 27.47% | 3.63% |
| 20-Day Relative Strength | 47.85% | 51.24% | 29.24% | 43.92% | 29.16% |
| Weighted Alpha | -88.72 | -13.18 | -33.86 | +8.53 | -23.14 |
| Today's Opinion | 88% Sell | 88% Buy | 88% Sell | 72% Sell | 100% Sell |
| Previous Opinion | 88% Sell | 88% Buy | 88% Sell | 40% Sell | 100% Sell |
| Last Month's Opinion | 100% Sell | 72% Buy | 8% Sell | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +29.34% since 04/18/24 | +2.59% since 04/18/24 | -6.57% since 04/18/24 | +2.13% since 04/18/24 | -0.80% since 04/18/24 |
| Low | 0.5400 on 04/19/24 | 99.30 on 04/22/24 | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 0.8290 on 04/25/24 | 111.29 on 04/24/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 |
| 1-Month | |||||
| %Chg | -4.04% since 03/25/24 | -5.20% since 03/25/24 | -13.64% since 03/25/24 | -4.44% since 03/25/24 | -9.58% since 03/25/24 |
| Low | 0.5400 on 04/19/24 | 97.00 on 04/03/24 | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 0.8290 on 04/25/24 | 115.89 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 |
| 3-Month | |||||
| %Chg | -33.13% since 01/25/24 | +1.78% since 01/25/24 | -9.04% since 01/25/24 | -13.51% since 01/25/24 | -18.20% since 01/25/24 |
| Low | 0.5400 on 04/19/24 | 84.06 on 02/13/24 | 44.67 on 04/25/24 | 260.68 on 04/19/24 | 65.32 on 04/25/24 |
| High | 1.2600 on 01/29/24 | 115.89 on 04/09/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 |
| 6-Month | |||||
| %Chg | -45.05% since 10/25/23 | +36.32% since 10/25/23 | -20.29% since 10/25/23 | -1.40% since 10/25/23 | -16.28% since 10/25/23 |
| Low | 0.5400 on 04/19/24 | 62.55 on 11/02/23 | 44.67 on 04/25/24 | 249.70 on 10/31/23 | 65.32 on 04/25/24 |
| High | 2.0500 on 01/09/24 | 115.97 on 01/08/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 110,161 | 41,676,488 | 99,027,448 | 146,436,016 | 83,519,768 |
| Shares Outstanding, K | 151,009 | 382,880 | 2,026,759 | 536,376 | 1,245,077 |
| Annual Sales | 126,330,000 | 6,848,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -113,720,000 | -4,714,000,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 60,000 | 2,811,000,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 |
| Last Quarter Net Income | -41,250,000 | 217,000,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 |
| 60-Month Beta | 2.23 | 1.62 | 0.39 | 0.58 | 0.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 03/05/24 | 0.55 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 |
| Latest Earnings Date | 05/14/24 | 05/02/24 | 04/25/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 |
| Next Ex-Dividends Date | N/A | N/A | 04/04/24 | 05/16/24 | 03/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.53 | 14.67 | 9.97 |